Abstract
BackgroundLenabasum (aka anabasum, JBT-101) is a selective cannabinoid receptor type 2 agonist that activates resolution of innate immune responses. It is a synthetic, oral, non-immunosuppressive small molecule. Lenabasum showed acceptable...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
